348 related articles for article (PubMed ID: 19391484)
1. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
[TBL] [Abstract][Full Text] [Related]
2. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(2):88-93. PubMed ID: 19886183
[TBL] [Abstract][Full Text] [Related]
4. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
5. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
Ermolli M; Schumacher M; Lods N; Hammoud M; Marti HP
Transpl Immunol; 2003; 11(2):137-45. PubMed ID: 12799196
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2006; 57(4):193-8. PubMed ID: 17285762
[TBL] [Abstract][Full Text] [Related]
8. A morphometric insight into glomerular and interstitial lesions in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2003; 54(3):171-7. PubMed ID: 14703283
[TBL] [Abstract][Full Text] [Related]
9. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
10. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
11. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
12. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof].
Zou HQ; Yao J; Wang YX; Wang J; Li D; Wang P
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):981-5. PubMed ID: 16061007
[TBL] [Abstract][Full Text] [Related]
13. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
Nicholson ML; Waller JR; Bicknell GR
Br J Surg; 2002 Jul; 89(7):933-7. PubMed ID: 12081746
[TBL] [Abstract][Full Text] [Related]
14. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
[TBL] [Abstract][Full Text] [Related]
15. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.
Zechel J; Gohil H; Lust WD; Cohen A
J Neurosci Res; 2002 Sep; 69(5):662-8. PubMed ID: 12210832
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
17. Indices of extracellular matrix turnover in human masseter muscles as markers of craniofacial form--a preliminary study.
Tippett HL; Dodgson LK; Hunt NP; Lewis MP
Eur J Orthod; 2008 Apr; 30(2):217-25. PubMed ID: 18263891
[TBL] [Abstract][Full Text] [Related]
18. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
20. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
